| ISIN | LU0848002365 |
|---|---|
| Valor Number | 19817651 |
| Bloomberg Global ID | UBSOEQA LX |
| Fund Name | UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) Q-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
| Asset Class | Equities |
| EFC Category | Equity Europe |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | This actively managed sub-fund predominantly invests in equities, equity rights or other equity interests in companies domiciled or chiefly active in Europe. The UBS ESG consensus score is used to identify issuers/companies for the investment universe with strong environmental and social performance characteristics, or a strong sustainability profile. |
| Peculiarities |
| Current Price * | 265.14 EUR | 05.11.2025 |
|---|---|---|
| Previous Price * | 264.14 EUR | 04.11.2025 |
| 52 Week High * | 268.66 EUR | 27.10.2025 |
| 52 Week Low * | 223.89 EUR | 09.04.2025 |
| NAV * | 265.14 EUR | 05.11.2025 |
| Issue Price * | 265.14 EUR | 05.11.2025 |
| Redemption Price * | 265.14 EUR | 05.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 358,689,608 | |
| Unit/Share Assets *** | 22,208,626 | |
| Trading Information SIX | ||
| YTD Performance | +9.58% |
31.12.2024 - 05.11.2025
31.12.2024 05.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +8.48% |
31.12.2024 - 05.11.2025
31.12.2024 05.11.2025 |
| 1 month | -0.08% |
06.10.2025 - 05.11.2025
06.10.2025 05.11.2025 |
| 3 months | +6.17% |
05.08.2025 - 05.11.2025
05.08.2025 05.11.2025 |
| 6 months | +4.26% |
05.05.2025 - 05.11.2025
05.05.2025 05.11.2025 |
| 1 year | +8.43% |
05.11.2024 - 05.11.2025
05.11.2024 05.11.2025 |
| 2 years | +20.73% |
06.11.2023 - 05.11.2025
06.11.2023 05.11.2025 |
| 3 years | +27.42% |
07.11.2022 - 05.11.2025
07.11.2022 05.11.2025 |
| 5 years | +34.96% |
05.11.2020 - 05.11.2025
05.11.2020 05.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 6.17% | |
|---|---|---|
| Banco Bilbao Vizcaya Argentaria SA | 3.85% | |
| Shell PLC | 3.48% | |
| Unilever PLC | 3.43% | |
| AstraZeneca PLC | 3.43% | |
| Lvmh Moet Hennessy Louis Vuitton SE | 3.39% | |
| NatWest Group PLC | 3.20% | |
| L'Oreal SA | 3.07% | |
| Danone SA | 3.03% | |
| Bank of Ireland Group PLC | 3.02% | |
| Last data update | 30.09.2025 | |
| TER | 1.01% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.72% |
| Ongoing Charges *** | 0.98% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |